Timothy S. Nelson, President and CEO at MAP Pharmaceuticals, Inc. (MAPP), sold 30,000 shares at $14.17 ($432K) on 2010-06-03, disclosed to the SEC on 2010-06-03.
Scheduled sale ($432k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.44 | 26,520 | $383K | 88.6% |
| 2 | $14.17 | 3,480 | $49K | 11.4% |
| Total | $14.41 avg | 30,000 | $432K | 100% |
| Filing → |
| MAPP | SELL | 2011-12-22 | $290K | — | Filing → |
| MAPP | SELL | 2010-07-02 | $182K | — | Filing → |
| MAPP | SELL | 2010-05-14 | $513K | — | Filing → |